Literature DB >> 10818091

Tau phosphorylation at serine 396 and serine 404 by human recombinant tau protein kinase II inhibits tau's ability to promote microtubule assembly.

D B Evans1, K B Rank, K Bhattacharya, D R Thomsen, M E Gurney, S K Sharma.   

Abstract

In Alzheimer's disease, hyperphosphorylated tau is an integral part of the neurofibrillary tangles that form within neuronal cell bodies and fails to promote microtubule assembly. Dysregulation of the brain-specific tau protein kinase II is reported to play an important role in the pathogenesis of Alzheimer's disease (Patrick, G. N., Zukerberg, L., Nikolic, M., De La Monte, S., Dikkes, P., and Tsai, L.-H. (1999) Nature 402, 615-622). We report here that in vitro phosphorylation of human tau by human recombinant tau protein kinase II severely inhibits the ability of tau to promote microtubule assembly as monitored by tubulin polymerization. The ultrastructure of tau-mediated polymerized tubulin was visualized by electron microscopy and compared with phosphorylated tau. Consistent with the observed slower kinetics of tubulin polymerization, phosphorylated tau is compromised in its ability to generate microtubules. Moreover, we show that phosphorylation of microtubule-associated tau results in tau's dissociation from the microtubules and tubulin depolymerization. Mutational studies with human tau indicate that phosphorylation by tau protein kinase II at serine 396 and serine 404 is primarily responsible for the functional loss of tau-mediated tubulin polymerization. These in vitro results suggest a possible role for tau protein kinase II-mediated tau phosphorylation in initiating the destabilization of microtubules.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10818091     DOI: 10.1074/jbc.M000808200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Increased Tau Phosphorylation in Motor Neurons From Clinically Pure Sporadic Amyotrophic Lateral Sclerosis Patients.

Authors:  Claire H Stevens; Natalie J Guthrie; Marloes van Roijen; Glenda M Halliday; Lezanne Ooi
Journal:  J Neuropathol Exp Neurol       Date:  2019-07-01       Impact factor: 3.685

2.  Lysophosphatidic acid induces neurite retraction in differentiated neuroblastoma cells via GSK-3β activation.

Authors:  Yuanjie Sun; Nam-Ho Kim; Haijie Yang; Seung-Hyuk Kim; Sung-Oh Huh
Journal:  Mol Cells       Date:  2011-04-14       Impact factor: 5.034

3.  Leptin reduces Alzheimer's disease-related tau phosphorylation in neuronal cells.

Authors:  Steven J Greco; Sraboni Sarkar; Jane M Johnston; Xiongwei Zhu; Bo Su; Gemma Casadesus; J Wesson Ashford; Mark A Smith; Nikolaos Tezapsidis
Journal:  Biochem Biophys Res Commun       Date:  2008-09-16       Impact factor: 3.575

4.  Two different docetaxel resistant MCF-7 sublines exhibited different gene expression pattern.

Authors:  Ozlem Darcansoy Işeri; Meltem Demirel Kars; Ufuk Gündüz
Journal:  Mol Biol Rep       Date:  2011-07-01       Impact factor: 2.316

5.  Proteasome inhibition drives HDAC6-dependent recruitment of tau to aggresomes.

Authors:  Chris R Guthrie; Brian C Kraemer
Journal:  J Mol Neurosci       Date:  2011-02-22       Impact factor: 3.444

6.  A Mouse Model of Repetitive Blast Traumatic Brain Injury Reveals Post-Trauma Seizures and Increased Neuronal Excitability.

Authors:  Vladislav Bugay; Eda Bozdemir; Fabio A Vigil; Sang H Chun; Deborah M Holstein; William R Elliott; Cassie J Sprague; Jose E Cavazos; David O Zamora; Gregory Rule; Mark S Shapiro; James D Lechleiter; Robert Brenner
Journal:  J Neurotrauma       Date:  2019-10-21       Impact factor: 5.269

7.  Phosphorylation-mimicking glutamate clusters in the proline-rich region are sufficient to simulate the functional deficiencies of hyperphosphorylated tau protein.

Authors:  J Eidenmüller; T Fath; T Maas; M Pool; E Sontag; R Brandt
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

8.  The Effects of Alpha Boswellic Acid on Reelin Expression and Tau Phosphorylation in Human Astrocytes.

Authors:  Esmat Fathi; Fatemeh Hedayati Katouli; Gholam Hossein Riazi; Marzieh Dehghan Shasaltaneh; Elham Parandavar; Samaneh Bayati; Ali Afrasiabi; Reza Nazari
Journal:  Neuromolecular Med       Date:  2016-08-27       Impact factor: 3.843

9.  Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau.

Authors:  Kim N Green; Joan S Steffan; Hilda Martinez-Coria; Xuemin Sun; Steven S Schreiber; Leslie Michels Thompson; Frank M LaFerla
Journal:  J Neurosci       Date:  2008-11-05       Impact factor: 6.167

10.  Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles.

Authors:  Antonella Caccamo; Salvatore Oddo; Lana X Tran; Frank M LaFerla
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.